We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,079 results
  1. Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process

    Background 

    Polypharmacy is a common global health concern in the older population. Deprescribing has been acknowledged as an important aspect of...

    Wuraola Akande-Sholabi, Comfort O. Ajilore, Temitope Ilori in BMC Primary Care
    Article Open access 25 January 2023
  2. „Deprescribing“ in DGPPN-S3-Leitlinien – eine systematische Analyse

    Background

    Deprescribing of medication or psychotherapy represents a critical phase in treatment. The aim of the work is to systematically analyze...

    Selina Seitz, Alkomiet Hasan, ... Theresa Halms in Der Nervenarzt
    Article 17 May 2024
  3. Towards a Prescription for Change: Interprofessional Management of Polypharmacy and Deprescribing

    Purpose of Review

    Deprescribing, systematically discontinuing unnecessary or harmful medications, gains importance in healthcare. With rising...

    Aimee Elizabeth Perron in Current Geriatrics Reports
    Article Open access 27 June 2024
  4. Measuring Quality of Life in Deprescribing Trials: A Sco** Review

    Background

    Quality of life (QoL) is an important outcome to capture in clinical trials evaluating deprescribing interventions.

    Objective ...
    Wade Thompson, Carina Lundby, ... Frank Moriarty in Drugs & Aging
    Article 06 May 2024
  5. Recommendations on deprescribing of bisphosphonates in osteoporosis guidelines: a systematic review

    Purpose

    Advancing age, declining health status, and a shift in benefit/risk balance warrant judicious use of preventive medications in older persons,...

    Ditte Beck Jepsen, Emilie Sofie Bergen, ... Carina Lundby in European Geriatric Medicine
    Article 02 July 2023
  6. Development and validation of the Medical Attitudes Towards Deprescribing Questionnaire

    Polypharmacy and inappropriate prescriptions in the elderly are widely discussed themes in scientific literature. Although more and more studies...

    Pasquale Agosti, Barbara D’Avanzo, ... Mauro Tettamanti in Internal and Emergency Medicine
    Article 20 December 2023
  7. eConsultation for Deprescribing Among Older Adults: Clinician Perspectives on Implementation Barriers and Facilitators

    Background

    Electronic consultations (eConsults) enable asynchronous consultation between primary care providers (PCPs) and specialists. eConsults have...

    Matthew E. Growdon, Lauren J. Hunt, ... Krista L. Harrison in Journal of General Internal Medicine
    Article 28 June 2024
  8. Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals

    Background

    The nursing home population is characterized by multimorbidity and disabilities, which often result in extensive prescription of medication...

    Anne G. R. Visser, Jenny B. G. Poddighe de-Bruijn, ... Jos M. G. A. Schols in Drugs & Aging
    Article Open access 29 January 2024
  9. Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing

    Background

    Opioids and benzodiazepines (BZDs) pose a public health problem. Older adults are especially susceptible to adverse events from opioids and...

    Casey J. Kelley, Joshua D. Niznik, ... Ellen Roberts in Drugs & Aging
    Article 04 October 2023
  10. Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey

    Background

    Deprescribing is a clinical intervention aimed at managing polypharmacy and improving older adults’ health outcomes. However, evidence...

    Sule Ajibola Saka, Tolulope Ruth Osineye in BMC Health Services Research
    Article Open access 24 May 2024
  11. Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers

    Summary

    Little is known about caregivers’ perspectives on deprescribing bisphosphonates for older adults with dementia. Caregivers agreed that...

    Joshua D. Niznik, Casey J. Kelley, ... Laura C. Hanson in Osteoporosis International
    Article 18 November 2023
  12. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework

    Background

    Efforts are needed to strengthen evidence and guidance for appropriate deprescribing for older nursing home (NH) residents, who are...

    Carolyn Thorpe, Joshua Niznik, Anna Li in BMC Geriatrics
    Article Open access 04 August 2023
  13. Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial

    Background

    Patients, family members, and clinicians express concerns about potential adverse drug withdrawal events (ADWEs) following medication...

    Cynthia M. Boyd, Susan M. Shetterly, ... Elizabeth A. Bayliss in Drugs & Aging
    Article 20 November 2023
  14. Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study

    Purpose

    To describe emotional barriers and facilitators to deprescribing (the planned reduction or discontinuation of medications) in older adults...

    Erika Ramsdale, Arul Malhotra, ... Paul R. Duberstein in Supportive Care in Cancer
    Article Open access 17 October 2023
  15. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium

    Recent medical advancements have increased life expectancy, leading to a surge in patients affected by multiple chronic diseases and consequent...

    Massimo Carollo, Virginia Boccardi, ... Nicola Veronese in Aging Clinical and Experimental Research
    Article Open access 08 March 2024
  16. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review

    Purpose of Review

    To summarise the evidence regarding which patients might benefit from deprescribing antihypertensive medications.

    Recent Findings ...
    James P. Sheppard, Athanase Benetos, ... Richard J. McManus in Current Hypertension Reports
    Article Open access 02 February 2024
  17. Deprescribing in older adults in a French community: a questionnaire study on patients’ beliefs and attitudes

    Background

    General practitioners (GPs) have a central role to play on reduction of polypharmacy and deprescribing. This study aimed to assess beliefs...

    Thibaut Geremie, Candy Guiguet-Auclair, ... Marie Blanquet in BMC Geriatrics
    Article Open access 27 June 2024
  18. Barriers and enablers to deprescribing of older adults and their caregivers: a systematic review and meta-synthesis

    Purpose

    The primary objective of this study was to identify the barriers and enablers to deprescribing from the viewpoint of community-dwelling older...

    Jennifer Bolt, Reema Abdoulrezzak, Colleen Inglis in European Geriatric Medicine
    Article 24 October 2023
  19. Outcomes in deprescribing implementation trials and compliance with expert recommendations: a systematic review

    Background

    Deprescribing, defined as discontinuing or reducing the dose of medications that are no longer needed or for which the risks outweigh the...

    Pierre Nizet, Adrien Evin, ... Jean-François Huon in BMC Geriatrics
    Article Open access 12 July 2023
  20. Pharmacists’ contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis

    Background

    Consolidated and reliable evidence regarding the effectiveness of pharmacist interventions for deprescribing benzodiazepines in older...

    Thiago Afonso Rodrigues Melo, Cleyton Oliveira Bezerra, ... Patricia Melo Aguiar in International Journal of Clinical Pharmacy
    Article 15 September 2023
Did you find what you were looking for? Share feedback.